Project Grant K23NS142570
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Alabama at Birmingham a $175,530 Project Grant, effective August 1, 2025 through July 31, 2029, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This research project develops objective neuroimaging-based biomarkers to measure three novel treatment targets for functional seizures (FS): sense of control over physical...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $580,614 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 1, 2025, through August 31, 2030. The award supports research investigating and validating Magnetic Resonance Spectroscopic Imaging and Thermometry (MRSI-T) as a non-invasive neuroimaging...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant of $438,836 to The Trustees of the Stevens Institute of Technology under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award supports research to develop a unified paradigm using simultaneous multimodal measurement of scalp EEG and intracranial EEG (iEEG) signals to estimate the electrophysiological networks of the whole brain....
- Federal Grant Award Summary The University of Pennsylvania received a $646,295 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded June 15, 2026, with completion targeted for May 31, 2031. The grant funds research to develop quantitative methods for assessing seizure network characteristics in patients with drug-resistant epilepsy, addressing...
- Grant Award Summary Baylor College of Medicine received a $100,228 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 30, 2026, with completion targeted for February 14, 2029. The award supports research on optimizing neurostimulation treatments for drug-resistant epilepsy through development of a novel platform combining...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $545,319 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded August 15, 2025, with completion targeted for July 31, 2030. The Sahel Epilepsy Epidemiology and Genomics Study (SEEG) delivers epidemiological and genetic research services to address critical gaps in epilepsy...
- Federal Project Grant Award Summary Beth Israel Deaconess Medical Center, Inc. received a $504,120 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) for the period May 1, 2026 through April 30, 2028. The award supports development and validation of SourceSpikeNet, a biophysically grounded artificial intelligence system designed to improve...
- Federal Project Grant Award Summary The University of Alabama at Birmingham received a $186,250 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded January 15, 2026, with a completion date of December 31, 2027. This research initiative investigates AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor function at interneuron...
- Federal Grant Award Summary Emory University received a $420,142 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 4, 2026 through April 30, 2028. The research project investigates the contribution of extracellular vesicles (EVs) to epileptogenesis in temporal lobe epilepsy (TLE) and Dravet syndrome (DS), two major forms of...
- Federal Project Grant Award Summary The University of Virginia received a $444,125 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded June 1, 2026, with a completion date of May 31, 2028. This research initiative addresses post-stroke seizures (PSS) and post-stroke epilepsy (PSE), complications that represent a significant clinical burden,...
The University of Alabama at Birmingham received a $237,870 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded June 1, 2026, with a completion date of May 31, 2031. This research initiative focuses on developing and validating electroencephalogram (EEG) source localization techniques applied to stereoelectroencephalography (SEEG) recordings to improve seizure onset zone identification in drug-resistant epilepsy patients. The project deliverables include systematic examination of SEEG source localization methods, assessment of accuracy and precision using stimulation-induced seizures, and advancement of SEEG source localization as a predictive tool for surgical outcomes. The primary research outputs will establish methodological frameworks for applying distributed source algorithms to intracranial EEG-recorded seizures, addressing current limitations in surgical localization that contribute to failure rates exceeding 60%. The project is designed to prepare for a larger prospective clinical trial comparing SEEG-based source localization with non-invasive scalp EEG and magnetoencephalography approaches, ultimately informing surgical decision-making and resection extent determination for epilepsy patients. This foundational research addresses a significant clinical need, as approximately one-third of epilepsy patients are drug-resistant and require surgical intervention dependent on precise seizure localization.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $237.9k | 6/3/26 |